Biotech startup Eikon Therapeutics raises $351 million

The round is the second largest for a biotech startup this year, behind only London-based Verdiva Bio, which creates treatments for obesity and cardiometabolic diseases, which raised $411 million in a Series A in January. Eikon uses ultra-high-resolution microscopy to…








